- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Shimadzu expands EchoView scanner line
Shimadzu will add the latest platform to its EchoView series ofultrasound scanners at next week's American Institute of Ultrasoundin Medicine meeting. The new system, SDU-2000, features 128-channelarchitecture with a hybrid beamformer. It is a
Shimadzu will add the latest platform to its EchoView series ofultrasound scanners at next week's American Institute of Ultrasoundin Medicine meeting. The new system, SDU-2000, features 128-channelarchitecture with a hybrid beamformer. It is a general-purposecolor-flow scanner targeted at cardiac, abdominal, vascular, andsuperficial applications. Shimadzu is also planning a power Dopplerupgrade for the scanner.
A fully configured SDU-2000 is expected to sell for a listprice of $85,000. SDU-2000 is pending 510(k) clearance from theFood and Drug Administration.
Another scanner in the EchoView line, SDU-350, received FDA510(k) clearance last month. That scanner is a lightweight, gray-scale,30-pound system that will retail for about $25,000.
Shimadzu, of Torrance, CA, debuted the EchoView technologyat last year's Radiological Society of North America meeting.The company also introduced its TrueVision probe technology, whichexpands the bandwidth of Shimadzu's probes to between 5 and 8MHz.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
